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Background: Oxygen supplementation is commonly given to the patients with severe pneumonia including
Legionella disease. Recent data suggested that apoptosis may play an important role, not only in the pathogenesis
of Legionella pneumonia, but also in oxygen-induced tissue damage. In the present study, the lethal sensitivity to
Legionella pneumonia were compared in the setting of hyperoxia between wild-type and Fas-deficient mice.
Findings: C57BL/6 mice and B6.MRL-Fas
lpr mice characterized with Fas-deficiency were used in this study. After
intratracheal administration of L. pneumophila, mice were kept in hyperoxic conditions (85-90% O2 conc.) in an
airtight chamber for 3 days. Bone-marrow derived macrophages infected with L. pneumophila were also kept in
hyperoxic conditions. Caspase activity and cytokine production were determined by using commercially available
kits. Smaller increases of several apoptosis markers, such as caspase-3 and -8, were demonstrated in Fas-deficient
mice, even though the bacterial burdens in Fas-deficient and wild type mice were similar. Bone-marrow derived
macrophages from Fas-deficient mice were shown to be more resistant to Legionella-induced cytotoxicity than
those from wild-type mice under hyperoxia.
Conclusions: These results demonstrated that Fas-mediated signaling and apoptosis may be a crucial factor in the
pathogenesis of Legionella pneumonia in the setting of hyperoxia.
Introduction
Legionella pneumophila is a Gram-negative intracellular
pathogen, and often causes a severe and life-threatening
pneumonia [1,2]. Legionella pneumonia is frequently
complicated with acute lung injury and acute respiratory
distress syndrome, which exaggerates the severity of this
disease [3,4]. Despite aggressive supportive care, includ-
ing antibiotic therapy and oxygen supplementation, high
mortality rates have been reported, especially in immu-
nocompromised patients [3,5,6].
Multiplication of L. pneumophila in lung tissue is
shown in several types of host cells, including macro-
phages, monocytes, and alveolar epithelial cells [7-9].
Previous reports showed that L. pneumophila can
induce apoptosis in macrophages and alveolar epithelial
cells [10-12]. Apoptosis is a highly regulated process of
cell death that is required for development and homeos-
tasis of multicellular organisms in physiological condi-
tion [13,14]. The two apoptosis pathways are the
extrinsic and intrinsic pathways [15]. The extrinsic path-
way is initiated by stimulation of the transmembrane
death receptors by specific ligands such as Fas, and then
procaspase 8 is proteolytically activated. Procaspase 8
proteolytically activates effectors proteins such as cas-
pase 3 and caspase 7. The intrinsic pathway is usually
activated by apoptotic signals such as cell stress. The sti-
muli cause changes to the inner mitochondrial perme-
ability and then cytochrome c is released into the
cytosol. The release of cytochrome c stimulates apopto-
some formation, and can lead to the activation of cas-
pase-9, and then of caspase-3. A wide variety of
pathogens were reported to modulate the host cell-
death pathway by direct interaction with key compo-
nents of the apoptosis machinery of the host [16,17].
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genesis of Legionella disease is incompletely understood.
Supplementation with oxygen is a critical part of sup-
portive care for severe pneumonia, including Legionella
infection, as an adjunct to intensive antibiotic che-
motherapy. Unfortunately, prolonged administration of
oxygen itself may be associated with exaggeration of
lung damage in these patients [18]. Recent progress in
this field suggests an important role for apoptosis in
hyperoxia-mediated lung injury in a variety of cells, such
as epithelial cells and microvascular endothelial cells
[19-21]. In a previous study, we found that hyperoxia
caused the development of acute lung injury and lethal-
ity in mice with Legionella pneumonia [22]. However,
only limited information is available for about the signif-
icance of hyperoxia in pathogenesis of Legionella pneu-
monia, especially from the standpoint of apoptosis in
the infected lungs.
In the present study, we examined Legionella pneumo-
nia associated with Fas-mediated apoptosis in the setting
of hyperoxia. To understand the mechanism of lethal
sensitivity, several apoptosis markers including caspase-
3, -8, and cytokine productions were explored.
Materials and methods
Animals
Specific pathogen-free 6-to 10-wk-old C57BL/6 mice
(Charles River Japan, Tokyo, Japan) and B6.MRL-Fas
lpr
mice characterized with Fas-deficiency (The Jackson
Laboratory, Bar Harbor, ME) were used. Fas-deficient
mice were bred in our animal facility. All mice were
housed in specific pathogen-free conditions within the
animal care facility at Laboratory Animal Research Cen-
t e ro fT o h oU n i v e r s i t yo fM e d i c i n eu n t i lt h ed a yo f
sacrifice (approved number #169).
Culture of Legionella organism and inoculation of bacteria
in vivo
We used a clinical isolate of L. pneumophila Suzuki
strain (serogroup 1) for all experiments. N-(2-aceta-
mido)-2-aminoethanesulfonic acid (Sigma-Aldrich, St.
Louis, MO)-buffered yeast extract (BYE) broth supple-
mented with L-cysteine (0.4 μg/ml) and ferric nitrate
(0.135 μg/ml) was used as liquid medium (BYE-broth).
To prepare solid medium, activated charcoal (2 μg/ml)
and agar (15 μg/ml) were added to liquid medium
(BCYE agar). L. pneumophila was incubated on BCYE-
agar for 4 days at 37°C. A single colony was transferred
to 3 ml of BYE-broth, and was then incubated overnight
at 37°C with constant shaking. The bacterial suspension
was again transferred to fresh BYE-broth, and incubated
overnight under the same conditions. The bacterial sus-
pension was diluted to the desired concentrations in sal-
ine according to a standard of absorbencies based on
known CFU. Animals were anesthetized intraperitone-
ally with 2.2 and 11.1 mg/kg xylazine and ketamine,
respectively. The trachea was exposed and 30 μlo f
inoculum was administrated via a sterile 26 gauge nee-
dle. The skin incision was closed with surgical staples.
Oxygen exposure in vivo
After intratracheal (i.t.) administration of bacteria, one
group of mice was kept in hyperoxic conditions in an
airtight chamber for 3 days, whereas another group was
placed in room air conditions according to our previous
studies [22,23]. For hyperoxic exposure, the oxygen con-
centration in the chamber was kept between 85 and
90% by a constant flow gas, which was monitored with
an in-line oxygen analyzer (O2 CONTROLLER model
MC-70, IIJIMA Electronics Corp. Japan) [22]. Carbon
dioxide levels in the chamber were maintained at 0.03-
0.04% during the course of experiments. Both groups of
mice were fed food and water ad lib and kept on a 12-h
dark night cycle at room temperature.
Lung harvesting for analysis
At designated time points, mice were sacrificed using
CO2 asphyxia. Before the lung removal, the pulmonary
vasculature was perfused with 1 ml of saline, via the
right ventricle. Whole lungs were then harvested for
assessment of bacterial number, cytokine protein expres-
sion, and apoptosis [22]. After the removal of whole
lungs, they were homogenized in 1.0 ml of saline using
at i s s u eh o m o g e n i z e r( O m n iT HH O M O G E N I Z E R ,
YAMATO scientific products Co,. Ltd., Tokyo) under a
vented hood. Portions of homogenates (10 μl) were
inoculated on agar after serial 1/10 dilutions with saline.
The remaining homogenates were centrifuged at 2000
rpm for 10 min in 4°C. Supernatants were collected, and
passed through a 0.45-μm filter (KANTO CHEMICAL
CO,. INC, Tokyo). These samples were stored at -20°C
for further analysis.
Oxygen exposure in vitro
The BM-derived macrophages infected with Legionella
in 96-well plates were kept in hyperoxic conditions in a
multi gas incubator (ASTEC Co,. Ltd, TOKYO) and
incubated at 37°C in 85-90% of oxygen and 5% of CO2.
In normoxia experiments, the plate was kept in 5% CO2
incubator during the course of experiments.
Preparation of bone-marrow derived macrophage
Murine bone-marrow (BM) derived macrophages were
prepared from control C57BL/6 and Fas-deficient mice
by the following method [24]. BM cells were extracted
from femurs, and suspended in RPMI with L-gluta-
mine added 10% fetal bovine serum (10 ml per
mouse). The BM cells in 2 ml were plated in the cell
Maeda et al. BMC Research Notes 2011, 4:107
http://www.biomedcentral.com/1756-0500/4/107
Page 2 of 7incubate dishes (BIOCOAT) and then added 8 ml (per
dish) of RPMI with L-glutamine containing L929 cell
conditioned medium (20%), fetal bovine serum (10%),
penicillin (100 U/ml) and streptomycin (100 μg/ml),
and 0.04% of M-CSF. The dishes were incubated at
37°C in humidified atmosphere of 5% CO2.A f t e r4
days, BM-derived macrophages in primary culture
were harvested and identified morphologically by the
adhesion of bottom of dish. The supernatant medium
was removed from the dishes and replaced with 5 ml
fresh medium (RPMI with L-glutamine added 10%
fetal bovine serum), and adherent macrophages peeled
with a rubber brush. Then, the cells in the medium
was collected and seeded at a concentration of
10
5 cell/well in a 96-well plate. After overnight incuba-
tion, each well was washed with the above medium
and infected with the desired concentrations of bac-
teria. After 2 hours of incubation, the wells were
washed with the medium to remove un-attached bac-
teria [25], and then the cells were incubated in 5%
CO2 with or without hyperoxia. After macrophages
were infected with L. pneumophila, shrunken cells
(apoptotic cells) but not necrosis cells were observed
by microscopic analysis (data not shown).
Determination of caspases activity
To evaluate induction of apoptosis, caspase-3 and -8
activities were determined in the homogenates of the
lungs of wild-type and Fas-deficient mice with pneumo-
nia. To confirm the activities of caspase cascade in
apoptosis, Caspase-3 and -8 activities were determined
by a colorimetric assay (R&D Systems, Minneapolis,
MN). The data were expressed as a fold increase, com-
paring to those of control mice (n = 5).
Murine cytokines ELISA
Murine cytokines (TNF-a, IL-6, IL-12) were quantitated
using specific ELISAs (R&D systems, Minneapolis, MN)
according to manufacturerers’ instructions.
Cell viability by Tetracolor
®
Incubated bone marrow-derived macrophages (after
Trypsin-EDTA treatment) were added in 96-well plates
(1 × 10
5 /well), and incubated for 24-48 hr at 37°C. 10
μl of Tetracolor ONE
® were added in each well and
incubated for 24 hr at 37°C. Measurement was deter-
mined by ELISA.
Statistical analysis
Statistical significance was determined using the
unpaired, two-tailed alternate Welch t test. Calculations
were performed using JSTAT for Windows (Masato
Sato, Japan). Statistic analyses of survival curves were
performed by using Delta Graph (SPSS Inc.).
Results
Bacterial number in the lungs of mice with Legionella
pneumonia
It has been reported that Fas-deficient mice may be
more resistant to Legionella pneumonia infection in the
setting of hyperoxia [22]. To explore the mechanisms of
lower lethality of Fas-deficient mice with Legionella
pneumonia in hyperoxia, we examined bacterial num-
bers in the lungs of wild-type and Fas-deficient mice.
The results demonstrated clearly no differences of the
bacterial numbers in the lungs between wild-type and
Fas-deficient mice, in both settings of normoxia and
hyperoxia (Figure 1). In in-vitro experiments using BM-
derived macrophages, we observed no differences of
bacterial numbers in macrophages derived from wild-
type and Fas-deficient mice, in despite of the condition
normoxia and hyperoxia (data not shown). These results
suggested that bacterial number may not be a critical
factor responsible for a mechanism of higher resistance
of Fas-deficient mice against Legionella pneumonia in
the setting of hyperoxia.
Effects of hyperoxia on Legionella-induced apoptosis in
the lungs of mice
In a previous study, we found that significantly lower
values of histone-associated DNA fragments were
observed in the lungs of Fas-deficient mice in hyperoxia
compared to in normoxic condition [22]. Therefore, we
examined the roles of apoptosis of Legionella pneumo-
























Figure 1 Bacterial numbers in the lungs of mice with L.
pneumophila. Wild-type and Fas-deficient mice were infected
intratracheally with approximately 10
6 CFU/mouse of L.
pneumophila. The mice of hyperoxia group were kept in hyperoxic
condition. The lungs were removed and homogenized at 48 hours
after the infection. The lung homogenates were incubated on BCYE-
a agar after serial 10-fold dilution for 4 days. The white column
represents the bacterial number in the lungs of wild-type mice
whereas the filled column represents the results of Fas-deficient
mice (n = 5).
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apoptosis) and caspase-8 (a marker of apoptosis asso-
ciated with the Fas-signaling system) in the lungs of
mice. For both markers, there were no differences in the
lungs between wild-type and Fas-deficient mice when
they were kept in normoxic condition (Figure 2). On the
other hand, significantly lower values of caspase-3 and
caspase-8 were observed in Fas-deficient mice under
hyperoxic condition. These results suggested less induc-
tion of apoptosis in the lungs of Fas-deficient mice kept
in hyperoxia, as evidenced by several factors, such as
histone-associated DNA fragments and caspase-3, cas-
pase-8.
Inflammatory cytokines in the lungs of wild-type and Fas-
deficient mice
We examined inflammatory cytokines, such as TNF-a,
IL-6 and IL-12, in the lungs of wild-type and Fas-defi-
cient mice kept in normoxic or hyperoxic condition
(Figure 3). In control mice, there was a trend of lower
values of these factors in the setting of hyperoxia. When
the values were compared in wild-type and Fas-deficient
mice, statistically significant differences were not
demonstrated between wild-type and Fas-deficient mice
in both normoxic and hyperoxic conditions.
Viability of BM-derived macrophages infected with L.
pneumophila
Finally, viability of BM-derived macrophages from wild-
type and Fas-deficient mice was compared after the
infection with L. pneumophila (Figure 4). In normoxic
condition, there were no differences of viability of
macrophages between wild-type and Fas-deficient mice.
On the other hand, significantly higher viability was
demonstrated in BM-derived macrophages from Fas-
deficient mice, when the infected cells were kept in
hyperoxia. Shrunken cells were frequently observed in
wild type mice in hyperoxia by microscopic analysis
(data not shown). These data suggested that BM-derived
macrophages from Fas-deficient mice may be more
resistant to L. pneumophila-induced cytotoxicity in the
setting of hyperoxia.
Discussion
Apoptosis can be triggered through two major pathways,
one implicating death receptor ligation (e.g. Fas and
TNF-a) and the other is the release of cytochrome c
from mitochondria [15]. In the lungs and pulmonary
cells, several investigators have reported that the Fas-
mediated signaling system may be an important devel-
opmental regulator for induction of apoptosis [26,27].
These “death-inducing” receptors recruit the death-
inducing signaling complex through interaction with
adaptor proteins, such as Fas associated death domain
protein (FADD). In turn, FADD recruits caspase-8.
Although a variety of known and unknown anti-apopto-
tic and pro-apoptotic factors may play a role, subse-
quent activation of proteases through mitochondria-
dependent or -independent pathways results in activa-
tion of the key effector enzyme, caspase-3. Activation of
executioner caspases results in DNA laddering, charac-
teristic of apoptotic cells, and to the cleavage of cytoske-
letal proteins. We observed less exaggerated changes of
the initiator caspase-8 and effector caspase -3 and DNA
fragmentation (histone-associated DNA fragments) in
the lungs of Fas-deficient mice under hyperoxia. How-
ever, how hyperoxia and Legionella infection are inter-
acting and exaggerating each other in the lungs of mice,
particularly the molecular role of Fas remains unknown.














































Figure 2 Caspase-3 and caspase-8 in the lungs of mice with L. pneumophila. Wild-type and Fas-deficient mice were infected intratracheally
with approximately 10
6 CFU/mouse of L. pneumophila. One group was kept in room air condition and another group was placed in a hyperoxic
condition. Lungs were removed and homogenized at 48 hours after the infection. Caspase activity was quantified by the ELISA, as described in
materials and methods. The white column represents the results of the lungs of wild-type mice whereas the filled column represents the results
of Fas-deficient mice (n = 5). *P<0.01, compared to those of wild-type mice.
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understanding of this.
Apoptosis has been described as a major death
mechanism in hyperoxia-induced lung injury in various
animal models in vivo [18,28-31]. Barazzone and colla-
borators have reported increased pulmonary Fas mRNA
levels in adult mice exposed to 100% oxygen, although
they failed to demonstrate survival advantage in Fas-
deficient lpr mice exposed to hyperoxia [21]. In concor-
dance with this finding, De Paepe and associates have
demonstrated that Fas gene silencing by siRNAs signifi-
cantly reduced hyperoxia-induced apoptosis [32]. In
contrast, several investigators have reported that other
apoptotic signaling pathways, such as mitochondrial
pathways and pro-apoptotic factor Bax, may participate
in the regulation of hyperoxia-induced cell death
[33-35]. Taken together, these data suggest that Fas-
mediated signaling and apoptosis, in addition to other
intrinsic apoptosis-regulating mechanisms, may be
involved in the pathogenesis of hyperoxia-induced lung
injuries.
L. pneumophila has been shown to induce apoptosis
within macrophages, monocytic cells and alveolar
epithelial cells [10,12]. Although the mechanisms of
L. pneumophila-associated apoptosis are not well under-
stood, there are at least two possibilities. The first is
that L. pneumophila may induce apoptosis through liga-
tion of death receptors, such as Fas and TNF-receptor,
by bacterial surface components or by secreted bacterial
factors. Another possibility is that translocation of apop-
totic factor(s), probably through the Dot/Icm secretion
machinery of bacteria, followed by direct activation of
caspases within the cytosol. Previously, Gao and Abu-
Kwaik demonstrated that activation of caspase-3, but
not caspase-1, is essential for apoptosis induced upon
infection by L. pneumophila [11], but the initial events
of caspase induction remained unclear at that time.
Molmeret and associates have shown that caspase-3
activation by L. pneumophila is independent of all the
known apoptotic pathways, such as the extrinsic and
intrinsic, that converge on the activation of caspase-3
[36]. Neumeister and collaborators have shown that
L. pneumophila induced comparable apoptosis in Fas-
positive and Fas-negative human monocytic cells, in
which correlated caspase activation and mitochondrial
cytochrome c release were demonstrated [37]. It seems
likely that apoptosis induced by L. pneumophila is inde-
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Figure 3 Cytokines in the lungs of mice with L. pneumophila. Wild-type (n = 5) and Fas-deficient mice (n = 5) were infected intratracheally
with approximately 10
6 CFU/mouse of L. pneumophila. One group was kept in room air condition and another group was placed in hyperoxic
condition. Lungs were removed and homogenized at 48 hours after the infection. TNF-a, IL-6 and IL-12 were quantified by the ELISA, as
described in materials and methods. The white column represents the results of the lungs of wild-type mice whereas the filled column




























Figure 4 BM-derived macrophages viability after infection with
L. pneumophila. BM-derived macrophages from wild-type and Fas-
deficient mice were prepared as described in materials and
methods. The cells were infected with L. pneumophila at MOI of 1
and then kept in 5% CO2 or 5%CO2 plus hyperoxia. The viability of
cells was examined 24 hours after the infection. The white column
is the results of the wild-type mice whereas the filled column
indicated results of Fas-deficient mice (n = 5).
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Fischer and associates have reported that caspase-8-defi-
cient Jurkat cells still underwent cell death, suggesting
that caspase-8 is not the relevant initiator caspase in
L. pneumophila-induced apoptosis [38]. These data sug-
gested that it may be important to consider the possibi-
lity of activation of apoptosis-related enzymes in a
retrograde fashion in L. pneumophila-induced apoptosis.
Several cytokines, chemokines and growth factors have
been reported to play a critical role in the pathogenesis
of hyperoxia-related lung injury. These include IL-6, IL-
8, IL-11, granulocyte-macrophage colony-stimulating
factor (GM-CSF) and keratinocyte growth factor (KGF).
In the present study, only limited cytokines were exam-
ined in L. pneumophila-infected lungs of wild-type and
Fas-deficient mice under hyperoxia. The data of TNF-a,
IL-6 and IL-12 demonstrated no characteristic changes
associated with lethality of mice and alterations in apop-
tosis markers. Further studies examining other factors,
such as IL-11, GM-CSF and KGF, may be important to
correctly characterize the roles and significance of cyto-
kines and growth factors in Legionella pneumonia under
hyperoxia.
The present data demonstrate that BM-macrophages
from Fas-deficient mice were more resistant to L. pneu-
mophila infection than those from wild-type mice in the
setting of hyperoxia. These data are consistent with the
survival data and the apoptosis markers in Fas-deficient
mice with L. pneumophila pneumonia. The Dot/Icm
secretion system of L. pneumophila may be a crucial fac-
tor determining cytotoxic effects of this organism,
because bacterial mutants deficient in this system
demonstrated a striking reduction of the capacity to
cause cytotoxicity through induction of apoptosis [36,39].
Although the mechanisms of this phenomenon remain
incompletely known, BM-derived M experiments may
provide an opportunity to examine an interaction
between Dot/Icm secretion system of L. pneumophila
and hyperoxia-mediated alterations in host cellular
defense systems.
The present data suggest that the blocking of apoptosis,
especially the Fas-mediated cascade, may be a potential
candidate for a new therapeutic approach against L.
pneumophila pneumonia under hyperoxia. Although it
may be critical to understand the molecular and cellular
pathogenesis of the events occurred in the lungs of these
individuals, silencing of Fas by siRNA and blocking of
Dot/Icm secretion system of L. pneumophila may be
attractive strategies. IAP (Inhibitor of apoptosis) family
proteins such as survivin may be potential candidates for
therapy [40]. In addition, antioxidants such as glutathione
may be also a potential therapeutic candidate [23,41].
Since L. pneumophila pneumonia is still a potentially
lethal infectious diseases and significant numbers of the
cases are treated with supplementation of high concen-
trations of oxygen, further investigations are warranted
for better understanding of the mechanisms of the dis-
eases and to search for life-saving therapeutic strategies.
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